Richard Rohde

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 5.9K citations · Full text

Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy

David Packham, Rory Wolfe, Anne T. Reutens et al. · Journal of the American Society of Nephrology · 2011 · 167 citations · Full text

Renal Pathology, Oxidative Stress, Glomerulonephritis +21

Captopril-induced reduction of serum levels of transforming growth Factor-β1 correlates with long-term renoprotection in insulin-dependent diabetic patients

Kumar Sharma, Babiker O. Eltayeb, Tracy McGowan et al. · American Journal of Kidney Diseases · 1999 · 160 citations

Metabolic Syndrome, Insulin Signaling, Signal Transduction +13

Remission of nephrotic range proteinuria in type I diabetes

Lee A. Hebert, Raymond P. Bain, Dante Verme et al. · Kidney International · 1994 · 127 citations · Full text

Glomerulonephritis, Renal Function, Renal Disease +6

Studies on the mechanisms of action of progesterone antagonists

W. Elger, S. Beier, Kristof Chwalisż et al. · Journal of Steroid Biochemistry · 1986 · 106 citations

Hormonal Contraceptive, Medicine, Hormonal Receptor +4